Safia Wazir

Temporal Trends, Cross-Country Inequality, and Future Burden of Mortality and DALYs Attributable to High Fasting Plasma Glucose in South Asia, 1990–2050: Forecasting, Validation, and Benchmarking Analysis Using the Global Burden of Disease 2023 Study

Background & Objective: High fasting plasma glucose (HFPG) is a major modifiable metabolic risk factor for cardiovascular disease, chronic kidney disease, premature mortality, and disability. South Asia faces a growing cardiometabolic burden, yet long-term country-level trends, inequalities, and future HFPG-attributabl...